Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study

Table 1 Sample characteristics

Characteristics	Value
Age mean and standard deviation	37 ± 9.68
Female sex, n (%)	455 (79.0)
BMI, mean, and standard deviation	42.8 ± 5.57
BMI classification, n (%)
Obesity Class I	04 (0.7)
Obesity Class II	121 (22.2)
Obesity Class III	420 (77.1)
Comorbidities, n (%)	446 (83.1)
DM	95 (17.2)
DM complications	11 (8.5)
SAH	234 (41.7)
Sleep apnea	75 (14)
Smoking	41 (7.7)
Dyslipidemia	210 (40.9)
Micronutrients, median (min-max)
Vitamin D, pg/mL	20 (4.2-52.2)
Vitamin B12, pg/mL	407 (36-2000)
Zinc, mg/L	6.6 (4-19.4)
Iron, mcg/dL	79 (8-408)
Magnesium, mg/dL	2.1 (1.3-2.9)
Steatosis, n (%)	604 (100.0)
0	42 (7.0)
1	221 (36.6)
2	182 (30.1)
3	159 (26.3)
NASH, n (%)	584 (100.0)
0	171 (29.3)
1	282 (48.3)
2	125 (21.4)
3	06 (1.0)
Fibrosis, n (%)	602 (100.0)
0	302 (50.2)
1	224 (37.2)
2	35 (5.8)
3	38 (6.3)
4	03 (0.5)

n = 614, sample size. BMI: Body mass index; DM: Diabetes mellitus; NASH: Nonalcoholic steatohepatitis; SAH: Systemic arterial hypertension.